Mettler Toledo International (MTD) Liabilities and Shareholders Equity (2009 - 2026)
Mettler Toledo International (MTD) recorded quarterly Liabilities and Shareholders Equity of $3.7 billion in Q1 2026, down 1.18% quarter-over-quarter from $3.7 billion in Q4 2025, and up 13.42% on a YoY basis from $3.2 billion in Q1 2025.
Mettler Toledo International (MTD) Liabilities and Shareholders Equity (2009 - 2026) Analysis & Trends
Mettler Toledo International's Liabilities and Shareholders Equity history runs 18 years deep, the most recent figure standing at $3.7 billion for Q1 2026.
- In Q1 2026, Liabilities and Shareholders Equity rose 13.42% year-over-year to $3.7 billion; the TTM figure through Mar 2026 stood at $14.3 billion (up 9.66% YoY), while the FY2025 annual figure was $3.7 billion, up 14.59% from the prior year.
- Liabilities and Shareholders Equity was $3.7 billion for Q1 2026 at Mettler Toledo International, down from $3.7 billion in the prior quarter.
- In the past five years, Liabilities and Shareholders Equity ranged from a high of $3.7 billion in Q4 2025 to a low of $3.2 billion in Q1 2025.
- Historically, Liabilities and Shareholders Equity has averaged $3.4 billion across 5 years, with a median of $3.4 billion in 2023.
- The sharpest annual moves came in 2023 and 2025: Liabilities and Shareholders Equity fell 3.92% in 2023, then grew 14.59% in 2025.
- A 5-year view of Liabilities and Shareholders Equity shows it stood at $3.5 billion in 2022, then slipped by 3.92% to $3.4 billion in 2023, then fell by 3.44% to $3.2 billion in 2024, then advanced by 14.59% to $3.7 billion in 2025, then retreated by 1.18% to $3.7 billion in 2026.
- The last three Liabilities and Shareholders Equity figures came in at $3.7 billion (Q1 2026), $3.7 billion (Q4 2025), and $3.5 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | 24.53 Bn |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | 113.28 Bn |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | 83.54 Bn |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | 3.39 Bn |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | 13.07 Bn |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | 2.61 Bn |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | 29.68 Bn |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | 6.56 Bn |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | 3.67 Bn |
| 10 | Quest Diagnostics | 22.51 Bn | 22.42 Bn | 942.00 Mn | 16.67 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.67 Bn |
| Dec 31, 2025 | 3.71 Bn |
| Sep 30, 2025 | 3.52 Bn |
| Jun 30, 2025 | 3.40 Bn |
| Mar 31, 2025 | 3.23 Bn |
| Dec 31, 2024 | 3.24 Bn |
| Sep 30, 2024 | 3.32 Bn |
| Jun 30, 2024 | 3.25 Bn |
| Mar 31, 2024 | 3.28 Bn |
| Dec 31, 2023 | 3.36 Bn |
| Sep 30, 2023 | 3.29 Bn |
| Jun 30, 2023 | 3.37 Bn |
| Mar 31, 2023 | 3.41 Bn |
| Dec 31, 2022 | 3.49 Bn |
| Sep 30, 2022 | 3.29 Bn |
| Jun 30, 2022 | 3.34 Bn |
| Mar 31, 2022 | 3.36 Bn |
| Dec 31, 2021 | 3.33 Bn |
| Sep 30, 2021 | 3.21 Bn |
| Jun 30, 2021 | 3.14 Bn |